Aerie Pharma (AERI) Misses Q4 EPS by 12c

Aerie Pharma (NASDAQ: AERI) reported Q4 EPS of ($0.58), $0.12 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Deutsche Bank monitors UK auto sales as Chinese exports grow
• Advance Auto Parts (AAP) PT Lowered to $43 at Truist Securities